{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[12]",
                    "[Percentage of Total G3+ Events]",
                    "[30.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Hepatobiliary disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "12",
                    "30.0%"
                ]
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Hepatobiliary disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[15]",
                    "[Percentage of Total G3+ Events]",
                    "[25.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Hepatobiliary disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "15",
                    "25.0%"
                ]
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[7]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[7]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[7]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[7]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[7]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[7]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[7]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[7]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[21.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[21.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[21.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[21.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[21.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[21.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[21.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Respiratory and thoracic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[21.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[6]",
                    "[Percentage of Total G3+ Events]",
                    "[15.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[6]",
                    "[Percentage of Total G3+ Events]",
                    "[15.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[6]",
                    "[Percentage of Total G3+ Events]",
                    "[15.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[6]",
                    "[Percentage of Total G3+ Events]",
                    "[15.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[6]",
                    "[Percentage of Total G3+ Events]",
                    "[15.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[6]",
                    "[Percentage of Total G3+ Events]",
                    "[15.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[6]",
                    "[Percentage of Total G3+ Events]",
                    "[15.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[6]",
                    "[Percentage of Total G3+ Events]",
                    "[15.0]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[10]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[10]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[10]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[10]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[10]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[10]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[10]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Blood and lymphatic disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[10]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[5]",
                    "[Percentage of Total G3+ Events]",
                    "[8.3]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[5]",
                    "[Percentage of Total G3+ Events]",
                    "[8.3]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[5]",
                    "[Percentage of Total G3+ Events]",
                    "[8.3]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[5]",
                    "[Percentage of Total G3+ Events]",
                    "[8.3]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[5]",
                    "[Percentage of Total G3+ Events]",
                    "[8.3]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[5]",
                    "[Percentage of Total G3+ Events]",
                    "[8.3]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[5]",
                    "[Percentage of Total G3+ Events]",
                    "[8.3]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Infections and infestations",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[5]",
                    "[Percentage of Total G3+ Events]",
                    "[8.3]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[3]",
                    "[Percentage of Total G3+ Events]",
                    "[7.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[4]",
                    "[Percentage of Total G3+ Events]",
                    "[6.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[4]",
                    "[Percentage of Total G3+ Events]",
                    "[6.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[4]",
                    "[Percentage of Total G3+ Events]",
                    "[6.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[4]",
                    "[Percentage of Total G3+ Events]",
                    "[6.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[4]",
                    "[Percentage of Total G3+ Events]",
                    "[6.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[4]",
                    "[Percentage of Total G3+ Events]",
                    "[6.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[4]",
                    "[Percentage of Total G3+ Events]",
                    "[6.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Metabolism and nutrition disorders",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[4]",
                    "[Percentage of Total G3+ Events]",
                    "[6.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[9]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[9]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[9]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[9]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[9]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[9]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[9]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[9]",
                    "[Percentage of Total G3+ Events]",
                    "[17.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Adverse Event SOC": "Other",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[13]",
                    "[Percentage of Total G3+ Events]",
                    "[16.7]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[20]",
                    "[Percentage of Total G3+ Events]",
                    "[47.6]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[20]",
                    "[Percentage of Total G3+ Events]",
                    "[47.6]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[20]",
                    "[Percentage of Total G3+ Events]",
                    "[47.6]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[20]",
                    "[Percentage of Total G3+ Events]",
                    "[47.6]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[20]",
                    "[Percentage of Total G3+ Events]",
                    "[47.6]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[20]",
                    "[Percentage of Total G3+ Events]",
                    "[47.6]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[20]",
                    "[Percentage of Total G3+ Events]",
                    "[47.6]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[20]",
                    "[Percentage of Total G3+ Events]",
                    "[47.6]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[34]",
                    "[Percentage of Total G3+ Events]",
                    "[15.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[34]",
                    "[Percentage of Total G3+ Events]",
                    "[15.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[34]",
                    "[Percentage of Total G3+ Events]",
                    "[15.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[34]",
                    "[Percentage of Total G3+ Events]",
                    "[15.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[34]",
                    "[Percentage of Total G3+ Events]",
                    "[15.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[34]",
                    "[Percentage of Total G3+ Events]",
                    "[15.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[34]",
                    "[Percentage of Total G3+ Events]",
                    "[15.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Total Number of Grade 3 or 4 Adverse Events": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[34]",
                    "[Percentage of Total G3+ Events]",
                    "[15.5]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[11]",
                    "[Percentage of Total G3+ Events]",
                    "[26.2]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[11]",
                    "[Percentage of Total G3+ Events]",
                    "[26.2]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[11]",
                    "[Percentage of Total G3+ Events]",
                    "[26.2]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[11]",
                    "[Percentage of Total G3+ Events]",
                    "[26.2]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[11]",
                    "[Percentage of Total G3+ Events]",
                    "[26.2]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[11]",
                    "[Percentage of Total G3+ Events]",
                    "[26.2]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[11]",
                    "[Percentage of Total G3+ Events]",
                    "[26.2]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-positive",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[11]",
                    "[Percentage of Total G3+ Events]",
                    "[26.2]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[14]",
                    "[Percentage of Total G3+ Events]",
                    "[6.4]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "17.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[14]",
                    "[Percentage of Total G3+ Events]",
                    "[6.4]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Infections and infestations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "9",
                    "15.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[14]",
                    "[Percentage of Total G3+ Events]",
                    "[6.4]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[14]",
                    "[Percentage of Total G3+ Events]",
                    "[6.4]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Gastrointestinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "8",
                    "13.3%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[14]",
                    "[Percentage of Total G3+ Events]",
                    "[6.4]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "5",
                    "12.5%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[14]",
                    "[Percentage of Total G3+ Events]",
                    "[6.4]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Investigations",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "7",
                    "11.7%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[14]",
                    "[Percentage of Total G3+ Events]",
                    "[6.4]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-positive"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "4",
                    "10.0%"
                ]
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "One or more grade 3 or 4 AE considered to be at least possibly related to treatment": "",
                    "HIV Status": "HIV-negative",
                    "Trial": "REMoxTB",
                    "Population": "Matched",
                    "Enrollment Phase": "Yes",
                    "Grade": "3 or 4"
                },
                "measures": "[Number of Events]",
                "outcomes": [
                    "[14]",
                    "[Percentage of Total G3+ Events]",
                    "[6.4]"
                ]
            },
            "Ground_truth_claim": {
                "subject": {
                    "trial": "REMoxTB",
                    "population": "matched population",
                    "phase": "enrolment",
                    "comparison": "HIV-positive vs HIV-negative patients",
                    "event severity": "Grade 3 or 4",
                    "event type": "Adverse Events (AEs)",
                    "filter": "five most frequently reported SOCs",
                    "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                    "HIV status": "HIV-negative"
                },
                "measures": [
                    "Count",
                    "Percentage of G3+ Events"
                ],
                "outcomes": [
                    "6",
                    "10.0%"
                ]
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 16,
    "total_ground_truth_claims": 10,
    "number_of_matches": 2
}